Releases
Found 42442 articles
Tradesman Nutrition Targets Skilled Trades With Specialized Supplement Line
Los Angeles-based Tradesman Nutrition has launched a consolidated supplement system tailored specifically for the physical demands of blue-collar labor. The new Ultimate Blue-Collar Stack organizes flagship products into a daily routine designed for the unique schedules of construction workers, mechanics, and other skilled professionals operating in intensive environments.
TCL Shifts Mobile Strategy Toward Display Innovation
At IFA 2026, TCL is pivoting its mobile strategy to balance high-performance hardware with its proprietary NXTPAPER display technology. By integrating this visual comfort system into AMOLED panels, the company aims to differentiate its smartphones from an increasingly crowded global market through specialized screen engineering and sustainable manufacturing practices.
Rosen Law Firm Probes Putnam Investments Over Misleading Disclosure Claims
Investors holding Putnam Investment Management, LLC mutual funds are under scrutiny as the Rosen Law Firm launches an investigation into potential securities violations. The legal action centers on allegations that the firm disseminated materially misleading business information, potentially damaging the financial interests of those who purchased the affected stock-based funds.
Investors Face September Deadline in Capricor Therapeutics Lawsuit
Investors who purchased Capricor Therapeutics securities between December 17, 2025, and July 26, 2026, have until September 28, 2026, to move the court to serve as lead plaintiff in an ongoing class action lawsuit alleging securities fraud against the biotechnology company.
Rosen Law Firm Probes Barclays Over Market Financial Solutions Exposure
Barclays shareholders face potential litigation as Rosen Law Firm investigates whether the banking giant misled investors regarding its exposure to the collapsed UK mortgage lender Market Financial Solutions Ltd. The inquiry follows reports that Barclays held 600 million pounds in credit linked to the failed firm, triggering significant share price volatility.
Investors Face October Deadline in HDFC Bank Securities Fraud Lawsuit
Investors who purchased HDFC Bank Limited securities between July 17, 2023, and May 26, 2026, face an October 13, 2026, deadline to apply as lead plaintiff in an ongoing class action lawsuit. The litigation targets alleged financial misconduct involving disguised payments and overstated interest income.
Investors Face September Deadline in Bloom Energy Securities Lawsuit
Investors who acquired Bloom Energy Corporation securities between February 27, 2025, and July 8, 2026, have until September 28, 2026, to apply for lead plaintiff status in a pending class action lawsuit. The litigation centers on allegations that the company misled shareholders regarding its dependency on Chinese-sourced scandium.
Investors Face October Deadline in DNOW Securities Class Action
Investors who held DNOW Inc. common stock as of the August 5, 2025, record date face an October 2, 2026, deadline to move the court to serve as lead plaintiff. The litigation, initiated by The Rosen Law Firm, centers on allegations that company leadership obscured material risks involving a merger integration.
Investors Face September Deadline in GPGI Securities Fraud Lawsuit
Investors who purchased Class A common stock of GPGI, Inc.—formerly CompoSecure—between November 2025 and May 2026 have until September 14, 2026, to file as lead plaintiffs. A class action lawsuit alleges the company misled shareholders regarding the financial health and underlying motives of its Husky acquisition.
Investors face September deadline in PROCEPT BioRobotics class action
Investors who purchased PROCEPT BioRobotics common stock between February 2024 and February 2026 have until September 22, 2026, to seek lead plaintiff status in a class action lawsuit. The litigation alleges the medical technology firm misled shareholders regarding its sales practices and inventory levels, leading to significant stock price declines.
TXNM Energy Prices $400 Million Common Stock Offering
Albuquerque-based TXNM Energy is tapping capital markets with a public offering of 7,079,646 shares priced at $56.50 each. The utility holding company expects to generate approximately $400 million in gross proceeds, which the firm plans to direct toward the full repayment of an outstanding term loan.
Baidu Shifts to Dual-Primary Listing on Hong Kong Stock Exchange
Baidu officially transitioned its secondary listing status to a dual-primary listing on the Main Board of the Hong Kong Stock Exchange today. This strategic shift places the Chinese AI giant on equal regulatory footing in Hong Kong and the United States, where it maintains its presence on the Nasdaq Global Select Market.
Ecopetrol Reshuffles Senior Leadership in Innovation and Energy Divisions
Colombia's state-controlled energy giant Ecopetrol announced a series of executive leadership changes on August 31, 2026, affecting its science, technology, and energy transition departments. The board’s latest resolutions mark a transition for both the corporate vice presidency of innovation and the executive vice presidency of energy transition.
Investors Scrutinize Elauwit Connection Following Revenue Discrepancies
A 6.8% drop in Elauwit Connection’s stock price has triggered a formal investigation by the Rosen Law Firm. The legal action centers on allegations that the company released misleading business information, specifically concerning revenue recognition errors identified in its 2025 interim financial filings.
Rosen Law Firm Probes Disc Medicine Over Misleading Disclosure Claims
A 22 percent plunge in Disc Medicine shares following a February regulatory setback has triggered a formal investigation by the Rosen Law Firm. Attorneys are now vetting potential securities claims, alleging the company provided investors with materially misleading information regarding its bitopertin drug development program.
XTI Aerospace Faces Nasdaq Delisting Risk Over Delayed Filing
XTI Aerospace has received a formal deficiency notice from Nasdaq after failing to file its second-quarter financial report on time. The delay stems from an ongoing internal review involving the company’s former CEO, who resigned abruptly on August 17, leaving the firm’s regulatory standing in a state of uncertainty.
Rosen Law Firm Investigates Flow Foundation Over Misleading Claims
Investors who held FLOW cryptocurrency between December 27 and December 29, 2025, are being recruited for a potential class action lawsuit. New York-based Rosen Law Firm claims the Flow Foundation may have released materially misleading business information, prompting a formal investigation into potential securities law violations and investor losses.
AAN and AHS Release Updated Migraine Prevention Guidelines
The American Academy of Neurology and the American Headache Society have issued a joint clinical update, replacing their 2012 standards to reflect a decade of research. The new guidance provides evidence-based recommendations for both episodic and chronic migraine, incorporating modern therapies alongside established pharmacological treatments for adult patients.
Investors Eye Lead Role in Securities Fraud Suit Against Pentwater Capital
Investors who purchased Avis Budget Group securities between February 20, 2025, and April 21, 2026, face a September 29 deadline to seek lead plaintiff status in a class action lawsuit. The litigation targets Pentwater Capital Management LP over allegations of market manipulation and orchestrating a massive short squeeze.
Bloom Energy Investors Face September Deadline in Securities Lawsuit
Investors who purchased Bloom Energy Corporation securities between February 27, 2025, and July 8, 2026, have until September 28, 2026, to file as lead plaintiffs in an ongoing class action lawsuit alleging the company misled shareholders regarding its supply chain and reliance on Chinese scandium.
Solidion Technology Expands Board with Three Financial Experts
Solidion Technology has appointed Kimi L. Ellen, Mark N. Schwartz, and Dante W. Robinson to its board of directors, effective August 31. The move expands the battery technology provider’s oversight team to seven members, with a majority now qualifying as independent under Nasdaq listing standards.
Genomma Lab Secures MXN 1 Billion Credit Facility from Banamex
Mexico City-based Genomma Lab Internacional has finalized a three-year, MXN 1 billion credit facility with Banamex to restructure its balance sheet. The pharmaceutical firm intends to use the capital to prepay existing bank loans and address upcoming maturities of its outstanding certificates, effectively optimizing its long-term debt profile.
Three Lions Acquisition Corp. Prices $100 Million Nasdaq IPO
Three Lions Acquisition Corp. has priced its initial public offering at $100 million, launching 10 million units at $10.00 each. The blank check company, which targets growth within the sports, hospitality, and real estate sectors, plans to begin trading on the Nasdaq Global Market under the ticker TLACU starting September 1.
Mixx Technologies Targets AI Inference Bottlenecks with SxC Connector
San Jose-based Mixx Technologies has unveiled the SxC Connector, a high-density optical interface capable of terminating 24,576 fibers in a single rack unit. Designed to address the scaling demands of hyperscale AI infrastructure, the hardware enables multi-petabit connectivity by streamlining both front-plane and back-plane optical integration.
Investors Eye Class Action Against UP Fintech Holding Limited
Shares of UP Fintech Holding Limited plummeted 25.3% on May 22, 2026, after Chinese regulators announced a sweeping crackdown on online brokers operating without local licenses. The market volatility, which followed reports of illegal cross-border securities activity, has triggered a new investigation by the Rosen Law Firm into potential investor losses.
Global PTFE Membranes Market Projected to Reach $2.84 Billion by 2031
The global market for polytetrafluoroethylene (PTFE) membranes is set for steady expansion, with valuations expected to climb from $2.14 billion in 2026 to $2.84 billion by 2031. Driven by a 5.8% compound annual growth rate, the sector is increasingly vital to pharmaceutical, semiconductor, and industrial filtration applications.
UWM Holdings Investors Face October Deadline for Class Action Suit
Investors who purchased UWM Holdings Corporation securities between March 9 and August 5, 2026, have until October 13 to seek lead plaintiff status in a federal class action lawsuit. The litigation follows a sharp 35% drop in share price triggered by substantial losses linked to failed hedging strategies.
Enliven Therapeutics to Present ELVN-001 Clinical Data at SOHO 2026
Enliven Therapeutics will showcase updated findings from its Phase 1 ENABLE trial during the Society of Hematologic Oncology annual meeting in Houston this September. The company plans to present both an oral report and a poster session detailing the performance of its lead candidate, ELVN-001, in treating chronic myeloid leukemia.
Ultra Violette Debuts First FDA-Approved Bemotrizinol Sunscreen in US
After a quarter-century of regulatory stagnation, the US suncare market is evolving. Australian brand Ultra Violette has introduced Unblock Screen SPF 50, marking the first time a product containing the broad-spectrum filter Bemotrizinol—recently cleared by the FDA—has reached American consumers.
Astellas Strikes Pricing Agreement with U.S. Government
Astellas Pharma has committed to lowering medicine prices within the Medicaid program as part of a new voluntary pact with the U.S. government. The agreement aims to balance corporate innovation with patient affordability, while also bolstering the nation’s emergency supply of critical transplant medication.